Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
PR Newswire•06/10/2026•09:00 ET
0
Key Highlights
- ➤Cognizant (CTSH) extends Gilead relationship for five years
- ➤Agreement expands selected DevOps and agentic AI technology programs
- ➤Cognizant has supported Gilead technology operations for more than a decade
- ➤Gilead will evaluate practical, responsible AI applications across its technology environment
Expert Statements
Anna Berg Asberg, Global CIO, Gilead Sciences
“Our focus is on giving our teams reliable, efficient technology that helps them move important work forward”
Anna Berg Asberg, Global CIO, Gilead Sciences
“This agreement provides additional support as we strengthen our DevOps capabilities and evaluate practical, responsible uses of AI across our technology environment—all in service of our broader mission to deliver for patients.”
Surya Gummadi, President, Americas, Cognizant
“We value the opportunity to continue supporting Gilead's technology priorities”
Surya Gummadi, President, Americas, Cognizant
“Our work will bring together life sciences experience, DevOps capabilities and AI tools to help Gilead improve delivery across selected programs.”
Mohammad Haque, Global Head of Intelligent Enterprise Platforms & Large Deals, Cognizant
“This agreement allows Cognizant to apply its technology capabilities and life sciences experience in support of Gilead's priorities.”
Mohammad Haque, Global Head of Intelligent Enterprise Platforms & Large Deals, Cognizant
“The work will focus on practical tools and approaches designed to support operational efficiency and program execution.”
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences PR Newswire
Five-year agreement will support selected Gilead technology programs
Get started
Create a free account to read the full story.